Published in
Elsevier, The Lancet Infectious Diseases, 8(12), p. 597-607, 2012
DOI: 10.1016/s1473-3099(12)70087-7
Links
Tools
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial
Journal article published in 2012 by
Peter C. Richmond 
,
Helen S. Marshall ,
Michael D. Nissen ,
Qin Jiang,
Kathrin U. Jansen,
Maria Garces-Sanchez,
Federico Martinon-Torres ,
Johannes Beeslaar,
Leszek Szenborn,
Joseph Eiden,
Jacek Wysocki,
Shannon L. Harris,
Thomas R. Jones,
John L. Perez
,
Helen S. Marshall ,
Michael D. Nissen ,
Qin Jiang,
Kathrin U. Jansen,
Maria Garces-Sanchez,
Federico Martinon-Torres ,
Johannes Beeslaar,
Leszek Szenborn,
Joseph Eiden,
Jacek Wysocki,
Shannon L. Harris,
Thomas R. Jones,
John L. Perez
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 